Summary

The global Brain Health Devices market is projected to grow from US$ 9061 million in 2024 to US$ 12200 million by 2031, at a CAGR of 4.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Brain Health Devices are used to check the health of the brain.
From a downstream perspective, Epilepsy accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Brain Health Devices leading manufacturers including Advanced Brain Health Device, BrainScope Company, Bio- Signal Group, Cadwell Laboratories, Inc., CAS Medical Systems, Inc., Covidien PLC, Compumedics Ltd., DePuy Synthes Companies, Elekta A.B, Electrical Geodesics Incorporated, etc., dominate supply; the top five capture approximately % of global revenue, with Advanced Brain Health Device leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Brain Health Devices market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Advanced Brain Health Device
BrainScope Company
Bio- Signal Group
Cadwell Laboratories, Inc.
CAS Medical Systems, Inc.
Covidien PLC
Compumedics Ltd.
DePuy Synthes Companies
Elekta A.B
Electrical Geodesics Incorporated
Integra Life Sciences Corporation
GE Healthcare
Medtronic Plc.
MEG International Services Ltd.
Natus Medical, Inc.
Neurowave Systems
Nihon Kohden Corporation
Philips Healthcare
Siemens Healthineers
Segment by Type
Electroencephalogram (EEG)
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Magnetoencephalogram (MEG)
Transcranial Doppler (TCD)
Intracranial Pressure (ICP)
Cerebral Oximeters
Segment by Application
Epilepsy
Dementia
Parkinson’s Disease
Huntington's Disease
Headache Disorders
Traumatic Brain Injuries
Sleep Disorders
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Brain Health Devices study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Brain Health Devices: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Brain Health Devices Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Electroencephalogram (EEG)
1.2.3 Computed Tomography (CT)
1.2.4 Magnetic Resonance Imaging (MRI)
1.2.5 Magnetoencephalogram (MEG)
1.2.6 Transcranial Doppler (TCD)
1.2.7 Intracranial Pressure (ICP)
1.2.8 Cerebral Oximeters
1.3 Market Segmentation by Application
1.3.1 Global Brain Health Devices Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Epilepsy
1.3.3 Dementia
1.3.4 Parkinson’s Disease
1.3.5 Huntington's Disease
1.3.6 Headache Disorders
1.3.7 Traumatic Brain Injuries
1.3.8 Sleep Disorders
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Brain Health Devices Revenue Estimates and Forecasts 2020-2031
2.2 Global Brain Health Devices Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Brain Health Devices Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Brain Health Devices Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Electroencephalogram (EEG) Market Size by Players
3.3.2 Computed Tomography (CT) Market Size by Players
3.3.3 Magnetic Resonance Imaging (MRI) Market Size by Players
3.3.4 Magnetoencephalogram (MEG) Market Size by Players
3.3.5 Transcranial Doppler (TCD) Market Size by Players
3.3.6 Intracranial Pressure (ICP) Market Size by Players
3.3.7 Cerebral Oximeters Market Size by Players
3.4 Global Brain Health Devices Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Brain Health Devices Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Brain Health Devices Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Brain Health Devices Market Size by Type (2020-2031)
6.4 North America Brain Health Devices Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Brain Health Devices Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Brain Health Devices Market Size by Type (2020-2031)
7.4 Europe Brain Health Devices Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Brain Health Devices Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Brain Health Devices Market Size by Type (2020-2031)
8.4 Asia-Pacific Brain Health Devices Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Brain Health Devices Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Brain Health Devices Market Size by Type (2020-2031)
9.4 Central and South America Brain Health Devices Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Brain Health Devices Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Brain Health Devices Market Size by Type (2020-2031)
10.4 Middle East and Africa Brain Health Devices Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Brain Health Devices Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Advanced Brain Health Device
11.1.1 Advanced Brain Health Device Corporation Information
11.1.2 Advanced Brain Health Device Business Overview
11.1.3 Advanced Brain Health Device Brain Health Devices Product Features and Attributes
11.1.4 Advanced Brain Health Device Brain Health Devices Revenue and Gross Margin (2020-2025)
11.1.5 Advanced Brain Health Device Brain Health Devices Revenue by Product in 2024
11.1.6 Advanced Brain Health Device Brain Health Devices Revenue by Application in 2024
11.1.7 Advanced Brain Health Device Brain Health Devices Revenue by Geographic Area in 2024
11.1.8 Advanced Brain Health Device Brain Health Devices SWOT Analysis
11.1.9 Advanced Brain Health Device Recent Developments
11.2 BrainScope Company
11.2.1 BrainScope Company Corporation Information
11.2.2 BrainScope Company Business Overview
11.2.3 BrainScope Company Brain Health Devices Product Features and Attributes
11.2.4 BrainScope Company Brain Health Devices Revenue and Gross Margin (2020-2025)
11.2.5 BrainScope Company Brain Health Devices Revenue by Product in 2024
11.2.6 BrainScope Company Brain Health Devices Revenue by Application in 2024
11.2.7 BrainScope Company Brain Health Devices Revenue by Geographic Area in 2024
11.2.8 BrainScope Company Brain Health Devices SWOT Analysis
11.2.9 BrainScope Company Recent Developments
11.3 Bio- Signal Group
11.3.1 Bio- Signal Group Corporation Information
11.3.2 Bio- Signal Group Business Overview
11.3.3 Bio- Signal Group Brain Health Devices Product Features and Attributes
11.3.4 Bio- Signal Group Brain Health Devices Revenue and Gross Margin (2020-2025)
11.3.5 Bio- Signal Group Brain Health Devices Revenue by Product in 2024
11.3.6 Bio- Signal Group Brain Health Devices Revenue by Application in 2024
11.3.7 Bio- Signal Group Brain Health Devices Revenue by Geographic Area in 2024
11.3.8 Bio- Signal Group Brain Health Devices SWOT Analysis
11.3.9 Bio- Signal Group Recent Developments
11.4 Cadwell Laboratories, Inc.
11.4.1 Cadwell Laboratories, Inc. Corporation Information
11.4.2 Cadwell Laboratories, Inc. Business Overview
11.4.3 Cadwell Laboratories, Inc. Brain Health Devices Product Features and Attributes
11.4.4 Cadwell Laboratories, Inc. Brain Health Devices Revenue and Gross Margin (2020-2025)
11.4.5 Cadwell Laboratories, Inc. Brain Health Devices Revenue by Product in 2024
11.4.6 Cadwell Laboratories, Inc. Brain Health Devices Revenue by Application in 2024
11.4.7 Cadwell Laboratories, Inc. Brain Health Devices Revenue by Geographic Area in 2024
11.4.8 Cadwell Laboratories, Inc. Brain Health Devices SWOT Analysis
11.4.9 Cadwell Laboratories, Inc. Recent Developments
11.5 CAS Medical Systems, Inc.
11.5.1 CAS Medical Systems, Inc. Corporation Information
11.5.2 CAS Medical Systems, Inc. Business Overview
11.5.3 CAS Medical Systems, Inc. Brain Health Devices Product Features and Attributes
11.5.4 CAS Medical Systems, Inc. Brain Health Devices Revenue and Gross Margin (2020-2025)
11.5.5 CAS Medical Systems, Inc. Brain Health Devices Revenue by Product in 2024
11.5.6 CAS Medical Systems, Inc. Brain Health Devices Revenue by Application in 2024
11.5.7 CAS Medical Systems, Inc. Brain Health Devices Revenue by Geographic Area in 2024
11.5.8 CAS Medical Systems, Inc. Brain Health Devices SWOT Analysis
11.5.9 CAS Medical Systems, Inc. Recent Developments
11.6 Covidien PLC
11.6.1 Covidien PLC Corporation Information
11.6.2 Covidien PLC Business Overview
11.6.3 Covidien PLC Brain Health Devices Product Features and Attributes
11.6.4 Covidien PLC Brain Health Devices Revenue and Gross Margin (2020-2025)
11.6.5 Covidien PLC Recent Developments
11.7 Compumedics Ltd.
11.7.1 Compumedics Ltd. Corporation Information
11.7.2 Compumedics Ltd. Business Overview
11.7.3 Compumedics Ltd. Brain Health Devices Product Features and Attributes
11.7.4 Compumedics Ltd. Brain Health Devices Revenue and Gross Margin (2020-2025)
11.7.5 Compumedics Ltd. Recent Developments
11.8 DePuy Synthes Companies
11.8.1 DePuy Synthes Companies Corporation Information
11.8.2 DePuy Synthes Companies Business Overview
11.8.3 DePuy Synthes Companies Brain Health Devices Product Features and Attributes
11.8.4 DePuy Synthes Companies Brain Health Devices Revenue and Gross Margin (2020-2025)
11.8.5 DePuy Synthes Companies Recent Developments
11.9 Elekta A.B
11.9.1 Elekta A.B Corporation Information
11.9.2 Elekta A.B Business Overview
11.9.3 Elekta A.B Brain Health Devices Product Features and Attributes
11.9.4 Elekta A.B Brain Health Devices Revenue and Gross Margin (2020-2025)
11.9.5 Elekta A.B Recent Developments
11.10 Electrical Geodesics Incorporated
11.10.1 Electrical Geodesics Incorporated Corporation Information
11.10.2 Electrical Geodesics Incorporated Business Overview
11.10.3 Electrical Geodesics Incorporated Brain Health Devices Product Features and Attributes
11.10.4 Electrical Geodesics Incorporated Brain Health Devices Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Integra Life Sciences Corporation
11.11.1 Integra Life Sciences Corporation Corporation Information
11.11.2 Integra Life Sciences Corporation Business Overview
11.11.3 Integra Life Sciences Corporation Brain Health Devices Product Features and Attributes
11.11.4 Integra Life Sciences Corporation Brain Health Devices Revenue and Gross Margin (2020-2025)
11.11.5 Integra Life Sciences Corporation Recent Developments
11.12 GE Healthcare
11.12.1 GE Healthcare Corporation Information
11.12.2 GE Healthcare Business Overview
11.12.3 GE Healthcare Brain Health Devices Product Features and Attributes
11.12.4 GE Healthcare Brain Health Devices Revenue and Gross Margin (2020-2025)
11.12.5 GE Healthcare Recent Developments
11.13 Medtronic Plc.
11.13.1 Medtronic Plc. Corporation Information
11.13.2 Medtronic Plc. Business Overview
11.13.3 Medtronic Plc. Brain Health Devices Product Features and Attributes
11.13.4 Medtronic Plc. Brain Health Devices Revenue and Gross Margin (2020-2025)
11.13.5 Medtronic Plc. Recent Developments
11.14 MEG International Services Ltd.
11.14.1 MEG International Services Ltd. Corporation Information
11.14.2 MEG International Services Ltd. Business Overview
11.14.3 MEG International Services Ltd. Brain Health Devices Product Features and Attributes
11.14.4 MEG International Services Ltd. Brain Health Devices Revenue and Gross Margin (2020-2025)
11.14.5 MEG International Services Ltd. Recent Developments
11.15 Natus Medical, Inc.
11.15.1 Natus Medical, Inc. Corporation Information
11.15.2 Natus Medical, Inc. Business Overview
11.15.3 Natus Medical, Inc. Brain Health Devices Product Features and Attributes
11.15.4 Natus Medical, Inc. Brain Health Devices Revenue and Gross Margin (2020-2025)
11.15.5 Natus Medical, Inc. Recent Developments
11.16 Neurowave Systems
11.16.1 Neurowave Systems Corporation Information
11.16.2 Neurowave Systems Business Overview
11.16.3 Neurowave Systems Brain Health Devices Product Features and Attributes
11.16.4 Neurowave Systems Brain Health Devices Revenue and Gross Margin (2020-2025)
11.16.5 Neurowave Systems Recent Developments
11.17 Nihon Kohden Corporation
11.17.1 Nihon Kohden Corporation Corporation Information
11.17.2 Nihon Kohden Corporation Business Overview
11.17.3 Nihon Kohden Corporation Brain Health Devices Product Features and Attributes
11.17.4 Nihon Kohden Corporation Brain Health Devices Revenue and Gross Margin (2020-2025)
11.17.5 Nihon Kohden Corporation Recent Developments
11.18 Philips Healthcare
11.18.1 Philips Healthcare Corporation Information
11.18.2 Philips Healthcare Business Overview
11.18.3 Philips Healthcare Brain Health Devices Product Features and Attributes
11.18.4 Philips Healthcare Brain Health Devices Revenue and Gross Margin (2020-2025)
11.18.5 Philips Healthcare Recent Developments
11.19 Siemens Healthineers
11.19.1 Siemens Healthineers Corporation Information
11.19.2 Siemens Healthineers Business Overview
11.19.3 Siemens Healthineers Brain Health Devices Product Features and Attributes
11.19.4 Siemens Healthineers Brain Health Devices Revenue and Gross Margin (2020-2025)
11.19.5 Siemens Healthineers Recent Developments
12 Brain Health DevicesIndustry Chain Analysis
12.1 Brain Health Devices Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Brain Health Devices Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Brain Health Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details